Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C24H19N3O

Zeng, Dai; Tan, Kai; Fang, Ziyan; Xing, Aiping

doi:10.1515/ncrs-2023-0372

Zeitschrift Für Kristallographie - New Crystal Structures

2023

DOI: 10.1515/ncrs-2023-0372

|View full text |Cite

Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C₂₄H₁₉N₃O

Dai Zeng,

Kai Tan,

Ziyan Fang

et al.

Abstract: C24H19N3O, monoclinic, P21/c (no. 14), a = 10.4783(5) Å, b = 11.7171(5) Å, c = 14.9194(6) Å, β = 93.991(2)°, Z = 4, V = 1827.29(14) Å3, R gt(F) = 0.0521, wR ref (F 2) = 0.1508, T = 150(2) K.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ² N,C]-(diethylamine-κ¹ N)platinum(II), C₁₆H₁₈ClN₂OPt

Xue

2024

Zeitschrift Für Kristallographie - New Crystal Structures

View full text Add to dashboard Cite

show abstract

Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ² N,C]-(diethylamine-κ¹ N)platinum(II), C₁₆H₁₈ClN₂OPt

Xue

2024

Zeitschrift Für Kristallographie - New Crystal Structures

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C₂₄H₁₉N₃O

Abstract: C24H19N3O, monoclinic, P21/c (no. 14), a = 10.4783(5) Å, b = 11.7171(5) Å, c = 14.9194(6) Å, β = 93.991(2)°, Z = 4, V = 1827.29(14) Å3, R gt(F) = 0.0521, wR ref (F 2) = 0.1508, T = 150(2) K.

Cited by 1 publication

References 11 publications

Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ² N,C]-(diethylamine-κ¹ N)platinum(II), C₁₆H₁₈ClN₂OPt

Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ² N,C]-(diethylamine-κ¹ N)platinum(II), C₁₆H₁₈ClN₂OPt

Contact Info

Product

Resources

About

Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C24H19N3O

Abstract: C24H19N3O, monoclinic, P21/c (no. 14), a = 10.4783(5) Å, b = 11.7171(5) Å, c = 14.9194(6) Å, β = 93.991(2)°, Z = 4, V = 1827.29(14) Å3, R gt(F) = 0.0521, wR ref (F 2) = 0.1508, T = 150(2) K.

Cited by 1 publication

References 11 publications

Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt

Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt

Contact Info

Product

Resources

About

Crystal structure of 2-(5-phenyl-1-(quinolin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenol, C₂₄H₁₉N₃O

Abstract: C24H19N3O, monoclinic, P21/c (no. 14), a = 10.4783(5) Å, b = 11.7171(5) Å, c = 14.9194(6) Å, β = 93.991(2)°, Z = 4, V = 1827.29(14) Å3, R gt(F) = 0.0521, wR ref (F 2) = 0.1508, T = 150(2) K.

Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ² N,C]-(diethylamine-κ¹ N)platinum(II), C₁₆H₁₈ClN₂OPt

Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ² N,C]-(diethylamine-κ¹ N)platinum(II), C₁₆H₁₈ClN₂OPt